AI MARKET SCANNING

$BIOPOR.CO

🔒 Europe

BioPorto A/S

🏛️ NASDAQ COPENHAGEN 📁 Healthcare 🏭 Diagnostics & Research
AVG HISTORICAL GAP +2.05%
MAX GAP RECORD +9.42%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $BIOPOR.CO
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN)
+0.61%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
-0.23%
Mar 20, 2025 Earnings Release 2025-03-20 (BEFORE OPEN)
+9.42%
Nov 14, 2024 Earnings Release 2024-11-14 (BEFORE OPEN)
+1.35%
Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE)
-0.21%
May 07, 2024 Earnings Release 2024-05-07 (BEFORE OPEN)
+1.37%
Aug 01, 2023 Earnings Release 2023-08-01 (BEFORE OPEN)
+1.74%
May 10, 2023 Earnings Release 2023-05-10 (BEFORE OPEN)
+2.37%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.2%
Bullish Gaps (5)
Bearish Gaps (0)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $BIOPOR.CO

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and Asia. It offers ProNephro AKI (NGAL), a test for pediatric acute kidney injury (AKI); NGAL Test, a…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗